Connplex Cinemas (CONNPLEX)

Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales compounding at 57.43% with profit growth of 36.08% shows strong demand and operating leverage.
• ROCE of 163.38% suggests exceptional efficiency in deploying capital.
• Promoter holding of 70.11% keeps management aligned with minority shareholders.
• Piotroski F-Score of 7/9 reflects solid current financial health.
• PEG of 0.44 indicates growth is not fully priced in at the current P/E of 20.40.

Concerns

• No book value, ROE, or debt/equity data disclosed, lacking the balance-sheet clarity Graham demanded.
• P/E of 20.40 leaves a thin margin of safety for a hit-driven, project-based film business.
• Latest quarter's ₹13 Cr profit annualizes well above the ₹22.45 Cr trailing earnings implied by the P/E; sustainability needs explanation.
• 0% dividend yield means no income return while waiting for growth to materialize.

AI Analysis

Looking at Connplex Cinemas, I see a fast-growing business, but I have learned to keep my excitement in check. Sales have grown 57.43%, profits 36.08%, and ROCE is a breathtaking 163.38%. A company putting capital to work at that rate has something special going for it. The Piotroski F-Score of 7/9 also tells me the financial health is currently sound. Promoter holding of 70.11% aligns the people who run the business with me and other minority shareholders, which I always respect. At ₹259.20, the P/E of 20.40 is not cheap, but with profit growth this strong, the PEG ratio of 0.44 says the market is not paying too much for that growth if it is durable. Yet I must be honest: the figures also raise red flags. There is no disclosed book value, no ROE, no debt/equity ratio. In Graham's world, an investor cannot judge safety without the balance sheet. The latest quarter shows net profit of ₹13 Cr on sales of ₹64 Cr, but the trailing earnings implied by the P/E is only about ₹22.45 Cr. That gap makes me question how representative one quarter really is. Film production, distribution and exhibition is inherently a hit-driven business; a single release can swing results. The 0% dividend yield means I am entirely dependent on reinvestment and a higher eventual price. I would not buy this blind. If the balance sheet is clean and the growth continues, this could be a wonderful compounding machine. But at a market cap of ₹458 Cr, there is little room for serious mistakes. I need more years of track record and margin of safety before committing. For now, it is a Fast Grower worth watching, not a classic Buffett buy by numbers alone.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer